Kyung Dong Pharmaceutical Co. Ltd (011040) — Cash Flow Reinvestment Rate
Kyung Dong Pharmaceutical Co. Ltd (011040) has a Cash Flow Reinvestment Rate of 8.45x as of December 2025, reinvesting ₩20.73 Billion (capex ₩10.48 Billion plus investments ₩10.25 Billion) from operating cash flow of ₩2.45 Billion. Explore how much does Kyung Dong Pharmaceutical Co. Ltd reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Kyung Dong Pharmaceutical Co. Ltd Cash Flow Reinvestment Rate (2011–2025)
Historical reinvestment intensity for Kyung Dong Pharmaceutical Co. Ltd across 11 annual periods. Also explore Kyung Dong Pharmaceutical Co. Ltd assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Kyung Dong Pharmaceutical Co. Ltd (2011–2025)
Year-by-year capital reinvestment analysis for Kyung Dong Pharmaceutical Co. Ltd. For live market cap and broader valuation context, see Kyung Dong Pharmaceutical Co. Ltd market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 2.03x | ₩34.36 Billion | ₩16.93 Billion | ₩20.51 Billion | ▲ +56.8% |
| 2021 | 1.29x | ₩16.07 Billion | ₩12.42 Billion | ₩3.93 Billion | ▼ -57.5% |
| 2020 | 3.05x | ₩52.12 Billion | ₩17.12 Billion | ₩28.59 Billion | ▲ +339.0% |
| 2018 | 0.69x | ₩23.07 Billion | ₩33.27 Billion | ₩3.93 Billion | ▲ +15.7% |
| 2017 | 0.60x | ₩8.86 Billion | ₩14.79 Billion | ₩5.74 Billion | ▲ +27.1% |
| 2016 | 0.47x | ₩12.09 Billion | ₩25.63 Billion | ₩7.19 Billion | ▼ -43.6% |
| 2015 | 0.84x | ₩15.27 Billion | ₩18.26 Billion | ₩11.10 Billion | ▼ -11.7% |
| 2014 | 0.95x | ₩21.53 Billion | ₩22.73 Billion | ₩21.17 Billion | ▲ +65.8% |
| 2013 | 0.57x | ₩9.38 Billion | ₩16.42 Billion | ₩9.38 Billion | ▲ +61.4% |
| 2012 | 0.35x | ₩7.06 Billion | ₩19.96 Billion | ₩7.06 Billion | ▲ +277.9% |
| 2011 | 0.09x | ₩2.44 Billion | ₩26.08 Billion | ₩2.44 Billion | — |